/
Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
Mentions
2 mentions · latest on 3 Sept 2026
See which tracked investors hold Revolution Medicines, Inc. →Ownership and position changes on OwnershipTrace